Publication:
Pulmonary Abnormalities in Congestive Heart Failure: Reversal by the Inhaled Anticholinergic Agent Ipratropium Bromide

Simple item page
dc.contributor.authorYesildag, O
dc.contributor.authorUnsal, M
dc.contributor.authorYazici, M
dc.contributor.authorBahadi, H
dc.contributor.authorYilmaz, O
dc.date.accessioned2020-06-21T15:49:49Z
dc.date.available2020-06-21T15:49:49Z
dc.date.issued2000
dc.departmentOMÜen_US
dc.department-tempOndokuz Mayis Univ, Fac Med, Dept Cardiol, Samsun, Turkey --en_US
dc.description.abstract…en_US
dc.identifier.endpage660en_US
dc.identifier.issn0195-668X
dc.identifier.startpage660en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/22307
dc.identifier.volume21en_US
dc.identifier.wosWOS:000089136602560
dc.language.isoenen_US
dc.publisherW B Saunders Co Ltden_US
dc.relation.journalEuropean Heart Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePulmonary Abnormalities in Congestive Heart Failure: Reversal by the Inhaled Anticholinergic Agent Ipratropium Bromideen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu